WO2004074298A1 - ホスホリルコリン基を有する化合物、その重合体ならびにその製造方法 - Google Patents
ホスホリルコリン基を有する化合物、その重合体ならびにその製造方法 Download PDFInfo
- Publication number
- WO2004074298A1 WO2004074298A1 PCT/JP2004/001794 JP2004001794W WO2004074298A1 WO 2004074298 A1 WO2004074298 A1 WO 2004074298A1 JP 2004001794 W JP2004001794 W JP 2004001794W WO 2004074298 A1 WO2004074298 A1 WO 2004074298A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- compound
- polymer
- general formula
- represented
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 105
- 229920000642 polymer Polymers 0.000 title claims abstract description 90
- NJNWCIAPVGRBHO-UHFFFAOYSA-N 2-hydroxyethyl-dimethyl-[(oxo-$l^{5}-phosphanylidyne)methyl]azanium Chemical group OCC[N+](C)(C)C#P=O NJNWCIAPVGRBHO-UHFFFAOYSA-N 0.000 title claims abstract description 56
- 238000000034 method Methods 0.000 title claims description 21
- -1 diamine compounds Chemical class 0.000 claims description 95
- 238000006243 chemical reaction Methods 0.000 claims description 58
- 239000000178 monomer Substances 0.000 claims description 22
- 238000004519 manufacturing process Methods 0.000 claims description 21
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 13
- 125000000217 alkyl group Chemical group 0.000 claims description 12
- 125000004432 carbon atom Chemical group C* 0.000 claims description 12
- 125000006239 protecting group Chemical group 0.000 claims description 12
- 125000003277 amino group Chemical group 0.000 claims description 10
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 9
- 150000001990 dicarboxylic acid derivatives Chemical class 0.000 claims description 8
- 238000006068 polycondensation reaction Methods 0.000 claims description 8
- 239000004202 carbamide Substances 0.000 claims description 5
- 125000005442 diisocyanate group Chemical group 0.000 claims description 5
- 125000005103 alkyl silyl group Chemical group 0.000 claims description 4
- 125000005002 aryl methyl group Chemical group 0.000 claims description 4
- 150000004292 cyclic ethers Chemical group 0.000 claims description 3
- 150000001991 dicarboxylic acids Chemical class 0.000 claims description 2
- OJMIONKXNSYLSR-UHFFFAOYSA-N phosphorous acid Chemical compound OP(O)O OJMIONKXNSYLSR-UHFFFAOYSA-N 0.000 claims description 2
- 230000008878 coupling Effects 0.000 claims 1
- 238000010168 coupling process Methods 0.000 claims 1
- 238000005859 coupling reaction Methods 0.000 claims 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 81
- 239000000243 solution Substances 0.000 description 57
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 41
- 238000003786 synthesis reaction Methods 0.000 description 41
- 230000015572 biosynthetic process Effects 0.000 description 37
- 239000002904 solvent Substances 0.000 description 37
- 239000000203 mixture Substances 0.000 description 29
- 239000010409 thin film Substances 0.000 description 29
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 28
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 27
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 24
- 238000001228 spectrum Methods 0.000 description 22
- 239000004952 Polyamide Substances 0.000 description 20
- 229920002647 polyamide Polymers 0.000 description 20
- 239000012300 argon atmosphere Substances 0.000 description 19
- 229920001577 copolymer Polymers 0.000 description 19
- 239000002244 precipitate Substances 0.000 description 19
- GTDPSWPPOUPBNX-UHFFFAOYSA-N ac1mqpva Chemical compound CC12C(=O)OC(=O)C1(C)C1(C)C2(C)C(=O)OC1=O GTDPSWPPOUPBNX-UHFFFAOYSA-N 0.000 description 17
- 239000007787 solid Substances 0.000 description 17
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 15
- 239000000843 powder Substances 0.000 description 15
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 14
- 239000004793 Polystyrene Substances 0.000 description 14
- 229920002223 polystyrene Polymers 0.000 description 14
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 14
- 101100435109 Homo sapiens PRNP gene Proteins 0.000 description 13
- 239000002253 acid Substances 0.000 description 13
- 238000000113 differential scanning calorimetry Methods 0.000 description 13
- 238000000635 electron micrograph Methods 0.000 description 13
- 230000009477 glass transition Effects 0.000 description 13
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 12
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 12
- 229920000139 polyethylene terephthalate Polymers 0.000 description 12
- 239000005020 polyethylene terephthalate Substances 0.000 description 12
- 239000010408 film Substances 0.000 description 11
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 239000012153 distilled water Substances 0.000 description 10
- 239000000463 material Substances 0.000 description 10
- 125000000962 organic group Chemical group 0.000 description 10
- 238000000807 solvent casting Methods 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 239000000758 substrate Substances 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 238000005481 NMR spectroscopy Methods 0.000 description 9
- 238000005227 gel permeation chromatography Methods 0.000 description 9
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- 235000002597 Solanum melongena Nutrition 0.000 description 8
- 238000001914 filtration Methods 0.000 description 8
- 238000002329 infrared spectrum Methods 0.000 description 8
- 239000004814 polyurethane Substances 0.000 description 8
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 7
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 7
- 229910052799 carbon Inorganic materials 0.000 description 7
- 238000004587 chromatography analysis Methods 0.000 description 7
- 239000005457 ice water Substances 0.000 description 7
- 239000012074 organic phase Substances 0.000 description 7
- 238000006116 polymerization reaction Methods 0.000 description 7
- 239000003507 refrigerant Substances 0.000 description 7
- 229910052938 sodium sulfate Inorganic materials 0.000 description 7
- 235000011152 sodium sulphate Nutrition 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 229910052786 argon Inorganic materials 0.000 description 6
- 230000007062 hydrolysis Effects 0.000 description 6
- 238000006460 hydrolysis reaction Methods 0.000 description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 6
- QQVIHTHCMHWDBS-UHFFFAOYSA-N isophthalic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 description 6
- 229920002635 polyurethane Polymers 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 6
- FDQSRULYDNDXQB-UHFFFAOYSA-N benzene-1,3-dicarbonyl chloride Chemical compound ClC(=O)C1=CC=CC(C(Cl)=O)=C1 FDQSRULYDNDXQB-UHFFFAOYSA-N 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- UWIULCYKVGIOPW-UHFFFAOYSA-N Glycolone Natural products CCOC1=C(CC=CC)C(=O)N(C)c2c(O)cccc12 UWIULCYKVGIOPW-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- OYQYHJRSHHYEIG-UHFFFAOYSA-N ethyl carbamate;urea Chemical compound NC(N)=O.CCOC(N)=O OYQYHJRSHHYEIG-UHFFFAOYSA-N 0.000 description 4
- 239000001294 propane Substances 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- 125000006158 tetracarboxylic acid group Chemical group 0.000 description 4
- 210000000689 upper leg Anatomy 0.000 description 4
- MEKOFIRRDATTAG-UHFFFAOYSA-N 2,2,5,8-tetramethyl-3,4-dihydrochromen-6-ol Chemical compound C1CC(C)(C)OC2=C1C(C)=C(O)C=C2C MEKOFIRRDATTAG-UHFFFAOYSA-N 0.000 description 3
- UPMLOUAZCHDJJD-UHFFFAOYSA-N 4,4'-Diphenylmethane Diisocyanate Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=C(N=C=O)C=C1 UPMLOUAZCHDJJD-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- HFACYLZERDEVSX-UHFFFAOYSA-N benzidine Chemical group C1=CC(N)=CC=C1C1=CC=C(N)C=C1 HFACYLZERDEVSX-UHFFFAOYSA-N 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000010511 deprotection reaction Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 229920001519 homopolymer Polymers 0.000 description 3
- DSWNRHCOGVRDOE-UHFFFAOYSA-N n,n-dimethylmethanimidamide Chemical compound CN(C)C=N DSWNRHCOGVRDOE-UHFFFAOYSA-N 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000010898 silica gel chromatography Methods 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- JCRRFJIVUPSNTA-UHFFFAOYSA-N 4-[4-(4-aminophenoxy)phenoxy]aniline Chemical compound C1=CC(N)=CC=C1OC(C=C1)=CC=C1OC1=CC=C(N)C=C1 JCRRFJIVUPSNTA-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 239000004642 Polyimide Substances 0.000 description 2
- 229920002396 Polyurea Polymers 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 238000007259 addition reaction Methods 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical compound [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 2
- 230000002785 anti-thrombosis Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000002473 artificial blood Substances 0.000 description 2
- 239000000560 biocompatible material Substances 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- VHRGRCVQAFMJIZ-UHFFFAOYSA-N cadaverine Chemical compound NCCCCCN VHRGRCVQAFMJIZ-UHFFFAOYSA-N 0.000 description 2
- 235000011089 carbon dioxide Nutrition 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 150000004985 diamines Chemical class 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 150000002009 diols Chemical class 0.000 description 2
- TVIDDXQYHWJXFK-UHFFFAOYSA-N dodecanedioic acid Chemical compound OC(=O)CCCCCCCCCCC(O)=O TVIDDXQYHWJXFK-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 239000012510 hollow fiber Substances 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- WLJVNTCWHIRURA-UHFFFAOYSA-N pimelic acid Chemical compound OC(=O)CCCCCC(O)=O WLJVNTCWHIRURA-UHFFFAOYSA-N 0.000 description 2
- 210000004623 platelet-rich plasma Anatomy 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920001721 polyimide Polymers 0.000 description 2
- 230000000379 polymerizing effect Effects 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000006722 reduction reaction Methods 0.000 description 2
- 238000007142 ring opening reaction Methods 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- TYFQFVWCELRYAO-UHFFFAOYSA-N suberic acid Chemical compound OC(=O)CCCCCCC(O)=O TYFQFVWCELRYAO-UHFFFAOYSA-N 0.000 description 2
- XFNJVJPLKCPIBV-UHFFFAOYSA-N trimethylenediamine Chemical compound NCCCN XFNJVJPLKCPIBV-UHFFFAOYSA-N 0.000 description 2
- HVLLSGMXQDNUAL-UHFFFAOYSA-N triphenyl phosphite Chemical compound C=1C=CC=CC=1OP(OC=1C=CC=CC=1)OC1=CC=CC=C1 HVLLSGMXQDNUAL-UHFFFAOYSA-N 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- LWBHHRRTOZQPDM-UHFFFAOYSA-N undecanedioic acid Chemical compound OC(=O)CCCCCCCCCC(O)=O LWBHHRRTOZQPDM-UHFFFAOYSA-N 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- FHBXQJDYHHJCIF-UHFFFAOYSA-N (2,3-diaminophenyl)-phenylmethanone Chemical compound NC1=CC=CC(C(=O)C=2C=CC=CC=2)=C1N FHBXQJDYHHJCIF-UHFFFAOYSA-N 0.000 description 1
- NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 description 1
- FZRJLBJACDITKM-UHFFFAOYSA-N 1,3,2-dioxaphospholane Chemical compound C1COPO1 FZRJLBJACDITKM-UHFFFAOYSA-N 0.000 description 1
- VGHSXKTVMPXHNG-UHFFFAOYSA-N 1,3-diisocyanatobenzene Chemical compound O=C=NC1=CC=CC(N=C=O)=C1 VGHSXKTVMPXHNG-UHFFFAOYSA-N 0.000 description 1
- WZCQRUWWHSTZEM-UHFFFAOYSA-N 1,3-phenylenediamine Chemical compound NC1=CC=CC(N)=C1 WZCQRUWWHSTZEM-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- ALQLPWJFHRMHIU-UHFFFAOYSA-N 1,4-diisocyanatobenzene Chemical compound O=C=NC1=CC=C(N=C=O)C=C1 ALQLPWJFHRMHIU-UHFFFAOYSA-N 0.000 description 1
- OVBFMUAFNIIQAL-UHFFFAOYSA-N 1,4-diisocyanatobutane Chemical compound O=C=NCCCCN=C=O OVBFMUAFNIIQAL-UHFFFAOYSA-N 0.000 description 1
- CBCKQZAAMUWICA-UHFFFAOYSA-N 1,4-phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 description 1
- DFPJRUKWEPYFJT-UHFFFAOYSA-N 1,5-diisocyanatopentane Chemical compound O=C=NCCCCCN=C=O DFPJRUKWEPYFJT-UHFFFAOYSA-N 0.000 description 1
- UTFSEWQOIIZLRH-UHFFFAOYSA-N 1,7-diisocyanatoheptane Chemical compound O=C=NCCCCCCCN=C=O UTFSEWQOIIZLRH-UHFFFAOYSA-N 0.000 description 1
- VLDPXPPHXDGHEW-UHFFFAOYSA-N 1-chloro-2-dichlorophosphoryloxybenzene Chemical compound ClC1=CC=CC=C1OP(Cl)(Cl)=O VLDPXPPHXDGHEW-UHFFFAOYSA-N 0.000 description 1
- BTFWJAUZPQUVNZ-UHFFFAOYSA-N 1-methyl-3-[(3-methylphenyl)methyl]benzene Chemical compound CC1=CC=CC(CC=2C=C(C)C=CC=2)=C1 BTFWJAUZPQUVNZ-UHFFFAOYSA-N 0.000 description 1
- RLYCRLGLCUXUPO-UHFFFAOYSA-N 2,6-diaminotoluene Chemical compound CC1=C(N)C=CC=C1N RLYCRLGLCUXUPO-UHFFFAOYSA-N 0.000 description 1
- FWFOYSJEPQHCFP-UHFFFAOYSA-N 2-benzoyloxy-2-oxoacetic acid Chemical compound OC(=O)C(=O)OC(=O)C1=CC=CC=C1 FWFOYSJEPQHCFP-UHFFFAOYSA-N 0.000 description 1
- LDLCZOVUSADOIV-UHFFFAOYSA-N 2-bromoethanol Chemical compound OCCBr LDLCZOVUSADOIV-UHFFFAOYSA-N 0.000 description 1
- SBMUNILHNJLMBF-UHFFFAOYSA-N 2-chloro-1,3,2$l^{5}-dioxaphospholane 2-oxide Chemical compound ClP1(=O)OCCO1 SBMUNILHNJLMBF-UHFFFAOYSA-N 0.000 description 1
- 125000003852 3-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C(Cl)=C1[H])C([H])([H])* 0.000 description 1
- GWUUUIMPMKEIAZ-UHFFFAOYSA-N 3-hydroxy-5-methoxycarbonylbenzoic acid Chemical compound COC(=O)C1=CC(O)=CC(C(O)=O)=C1 GWUUUIMPMKEIAZ-UHFFFAOYSA-N 0.000 description 1
- WECDUOXQLAIPQW-UHFFFAOYSA-N 4,4'-Methylene bis(2-methylaniline) Chemical compound C1=C(N)C(C)=CC(CC=2C=C(C)C(N)=CC=2)=C1 WECDUOXQLAIPQW-UHFFFAOYSA-N 0.000 description 1
- YBRVSVVVWCFQMG-UHFFFAOYSA-N 4,4'-diaminodiphenylmethane Chemical compound C1=CC(N)=CC=C1CC1=CC=C(N)C=C1 YBRVSVVVWCFQMG-UHFFFAOYSA-N 0.000 description 1
- AVCOFPOLGHKJQB-UHFFFAOYSA-N 4-(3,4-dicarboxyphenyl)sulfonylphthalic acid Chemical compound C1=C(C(O)=O)C(C(=O)O)=CC=C1S(=O)(=O)C1=CC=C(C(O)=O)C(C(O)=O)=C1 AVCOFPOLGHKJQB-UHFFFAOYSA-N 0.000 description 1
- HNHQPIBXQALMMN-UHFFFAOYSA-N 4-[(3,4-dicarboxyphenyl)-dimethylsilyl]phthalic acid Chemical compound C=1C=C(C(O)=O)C(C(O)=O)=CC=1[Si](C)(C)C1=CC=C(C(O)=O)C(C(O)=O)=C1 HNHQPIBXQALMMN-UHFFFAOYSA-N 0.000 description 1
- IWXCYYWDGDDPAC-UHFFFAOYSA-N 4-[(3,4-dicarboxyphenyl)methyl]phthalic acid Chemical compound C1=C(C(O)=O)C(C(=O)O)=CC=C1CC1=CC=C(C(O)=O)C(C(O)=O)=C1 IWXCYYWDGDDPAC-UHFFFAOYSA-N 0.000 description 1
- DZIHTWJGPDVSGE-UHFFFAOYSA-N 4-[(4-aminocyclohexyl)methyl]cyclohexan-1-amine Chemical compound C1CC(N)CCC1CC1CCC(N)CC1 DZIHTWJGPDVSGE-UHFFFAOYSA-N 0.000 description 1
- ZYEDGEXYGKWJPB-UHFFFAOYSA-N 4-[2-(4-aminophenyl)propan-2-yl]aniline Chemical compound C=1C=C(N)C=CC=1C(C)(C)C1=CC=C(N)C=C1 ZYEDGEXYGKWJPB-UHFFFAOYSA-N 0.000 description 1
- AUOBMHBCOTUSTJ-UHFFFAOYSA-N 4-[4-[2-[4-(4-aminophenoxy)phenyl]propyl]phenoxy]aniline Chemical compound C=1C=C(OC=2C=CC(N)=CC=2)C=CC=1C(C)CC(C=C1)=CC=C1OC1=CC=C(N)C=C1 AUOBMHBCOTUSTJ-UHFFFAOYSA-N 0.000 description 1
- OYGUOZYRZNPDTN-UHFFFAOYSA-N 4-[6-(3,4-dicarboxyphenoxy)pyridin-2-yl]oxyphthalic acid Chemical compound C1=C(C(O)=O)C(C(=O)O)=CC=C1OC1=CC=CC(OC=2C=C(C(C(O)=O)=CC=2)C(O)=O)=N1 OYGUOZYRZNPDTN-UHFFFAOYSA-N 0.000 description 1
- ZVNPWFOVUDMGRP-UHFFFAOYSA-N 4-methylaminophenol sulfate Chemical compound OS(O)(=O)=O.CNC1=CC=C(O)C=C1.CNC1=CC=C(O)C=C1 ZVNPWFOVUDMGRP-UHFFFAOYSA-N 0.000 description 1
- ATZHGRNFEFVDDJ-UHFFFAOYSA-N 4-propylbenzoic acid Chemical compound CCCC1=CC=C(C(O)=O)C=C1 ATZHGRNFEFVDDJ-UHFFFAOYSA-N 0.000 description 1
- YGYCECQIOXZODZ-UHFFFAOYSA-N 4415-87-6 Chemical compound O=C1OC(=O)C2C1C1C(=O)OC(=O)C12 YGYCECQIOXZODZ-UHFFFAOYSA-N 0.000 description 1
- VQVIHDPBMFABCQ-UHFFFAOYSA-N 5-(1,3-dioxo-2-benzofuran-5-carbonyl)-2-benzofuran-1,3-dione Chemical compound C1=C2C(=O)OC(=O)C2=CC(C(C=2C=C3C(=O)OC(=O)C3=CC=2)=O)=C1 VQVIHDPBMFABCQ-UHFFFAOYSA-N 0.000 description 1
- 101100132433 Arabidopsis thaliana VIII-1 gene Proteins 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- HLIVOPCNRCEXOX-UHFFFAOYSA-N C(=O)(O)C1=CC=C(OC2=C(C=CC=C2)CCC)C=C1 Chemical compound C(=O)(O)C1=CC=C(OC2=C(C=CC=C2)CCC)C=C1 HLIVOPCNRCEXOX-UHFFFAOYSA-N 0.000 description 1
- OHJOYNAAELSFBP-UHFFFAOYSA-O C(C(=C)C)(=O)C1(OC=C1)P(=O)=C(O)C[N+](C)(C)C Chemical compound C(C(=C)C)(=O)C1(OC=C1)P(=O)=C(O)C[N+](C)(C)C OHJOYNAAELSFBP-UHFFFAOYSA-O 0.000 description 1
- MQJKPEGWNLWLTK-UHFFFAOYSA-N Dapsone Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=C1 MQJKPEGWNLWLTK-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- XEUCQOBUZPQUMQ-UHFFFAOYSA-N Glycolone Chemical compound COC1=C(CC=C(C)C)C(=O)NC2=C1C=CC=C2OC XEUCQOBUZPQUMQ-UHFFFAOYSA-N 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 239000005057 Hexamethylene diisocyanate Substances 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 239000012448 Lithium borohydride Substances 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- UKLDJPRMSDWDSL-UHFFFAOYSA-L [dibutyl(dodecanoyloxy)stannyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)O[Sn](CCCC)(CCCC)OC(=O)CCCCCCCCCCC UKLDJPRMSDWDSL-UHFFFAOYSA-L 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- BALIDSJNGIOVDT-UHFFFAOYSA-N anthracene-1,2,5,6-tetracarboxylic acid Chemical compound OC(=O)C1=C(C(O)=O)C=CC2=CC3=C(C(O)=O)C(C(=O)O)=CC=C3C=C21 BALIDSJNGIOVDT-UHFFFAOYSA-N 0.000 description 1
- XAAYMWLCUICVSL-UHFFFAOYSA-N anthracene-2,6-dicarboxylic acid Chemical compound C1=C(C(O)=O)C=CC2=CC3=CC(C(=O)O)=CC=C3C=C21 XAAYMWLCUICVSL-UHFFFAOYSA-N 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 229910000175 cerite Inorganic materials 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- DMSZORWOGDLWGN-UHFFFAOYSA-N ctk1a3526 Chemical compound NP(N)(N)=O DMSZORWOGDLWGN-UHFFFAOYSA-N 0.000 description 1
- STZIXLPVKZUAMV-UHFFFAOYSA-N cyclopentane-1,1,2,2-tetracarboxylic acid Chemical compound OC(=O)C1(C(O)=O)CCCC1(C(O)=O)C(O)=O STZIXLPVKZUAMV-UHFFFAOYSA-N 0.000 description 1
- YQLZOAVZWJBZSY-UHFFFAOYSA-N decane-1,10-diamine Chemical compound NCCCCCCCCCCN YQLZOAVZWJBZSY-UHFFFAOYSA-N 0.000 description 1
- 239000012975 dibutyltin dilaurate Substances 0.000 description 1
- ZFTFAPZRGNKQPU-UHFFFAOYSA-N dicarbonic acid Chemical class OC(=O)OC(O)=O ZFTFAPZRGNKQPU-UHFFFAOYSA-N 0.000 description 1
- 125000001142 dicarboxylic acid group Chemical group 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Natural products C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 1
- VDCSGNNYCFPWFK-UHFFFAOYSA-N diphenylsilane Chemical compound C=1C=CC=CC=1[SiH2]C1=CC=CC=C1 VDCSGNNYCFPWFK-UHFFFAOYSA-N 0.000 description 1
- QFTYSVGGYOXFRQ-UHFFFAOYSA-N dodecane-1,12-diamine Chemical compound NCCCCCCCCCCCCN QFTYSVGGYOXFRQ-UHFFFAOYSA-N 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- PWSKHLMYTZNYKO-UHFFFAOYSA-N heptane-1,7-diamine Chemical compound NCCCCCCCN PWSKHLMYTZNYKO-UHFFFAOYSA-N 0.000 description 1
- SXCBDZAEHILGLM-UHFFFAOYSA-N heptane-1,7-diol Chemical compound OCCCCCCCO SXCBDZAEHILGLM-UHFFFAOYSA-N 0.000 description 1
- RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 description 1
- XXMIOPMDWAUFGU-UHFFFAOYSA-N hexane-1,6-diol Chemical compound OCCCCCCO XXMIOPMDWAUFGU-UHFFFAOYSA-N 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000006358 imidation reaction Methods 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- XJRAOMZCVTUHFI-UHFFFAOYSA-N isocyanic acid;methane Chemical compound C.N=C=O.N=C=O XJRAOMZCVTUHFI-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- OBKARQMATMRWQZ-UHFFFAOYSA-N naphthalene-1,2,5,6-tetracarboxylic acid Chemical compound OC(=O)C1=C(C(O)=O)C=CC2=C(C(O)=O)C(C(=O)O)=CC=C21 OBKARQMATMRWQZ-UHFFFAOYSA-N 0.000 description 1
- VAWFFNJAPKXVPH-UHFFFAOYSA-N naphthalene-1,6-dicarboxylic acid Chemical compound OC(=O)C1=CC=CC2=CC(C(=O)O)=CC=C21 VAWFFNJAPKXVPH-UHFFFAOYSA-N 0.000 description 1
- DOBFTMLCEYUAQC-UHFFFAOYSA-N naphthalene-2,3,6,7-tetracarboxylic acid Chemical compound OC(=O)C1=C(C(O)=O)C=C2C=C(C(O)=O)C(C(=O)O)=CC2=C1 DOBFTMLCEYUAQC-UHFFFAOYSA-N 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- SXJVFQLYZSNZBT-UHFFFAOYSA-N nonane-1,9-diamine Chemical compound NCCCCCCCCCN SXJVFQLYZSNZBT-UHFFFAOYSA-N 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- RGSFGYAAUTVSQA-UHFFFAOYSA-N pentamethylene Natural products C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 1
- YHHSONZFOIEMCP-UHFFFAOYSA-O phosphocholine Chemical group C[N+](C)(C)CCOP(O)(O)=O YHHSONZFOIEMCP-UHFFFAOYSA-O 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- VBQCHPIMZGQLAZ-UHFFFAOYSA-N phosphorane Chemical class [PH5] VBQCHPIMZGQLAZ-UHFFFAOYSA-N 0.000 description 1
- 229950004354 phosphorylcholine Drugs 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920005575 poly(amic acid) Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- JRDBISOHUUQXHE-UHFFFAOYSA-N pyridine-2,3,5,6-tetracarboxylic acid Chemical compound OC(=O)C1=CC(C(O)=O)=C(C(O)=O)N=C1C(O)=O JRDBISOHUUQXHE-UHFFFAOYSA-N 0.000 description 1
- 229920005604 random copolymer Polymers 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 239000010948 rhodium Substances 0.000 description 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000000037 tert-butyldiphenylsilyl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1[Si]([H])([*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
- DVKJHBMWWAPEIU-UHFFFAOYSA-N toluene 2,4-diisocyanate Chemical compound CC1=CC=C(N=C=O)C=C1N=C=O DVKJHBMWWAPEIU-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- SKBYLXMJUREDGV-UHFFFAOYSA-N triphenyl phosphate;zinc Chemical compound [Zn].C=1C=CC=CC=1OP(OC=1C=CC=CC=1)(=O)OC1=CC=CC=C1 SKBYLXMJUREDGV-UHFFFAOYSA-N 0.000 description 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 238000007740 vapor deposition Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/6574—Esters of oxyacids of phosphorus
- C07F9/65742—Esters of oxyacids of phosphorus non-condensed with carbocyclic rings or heterocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/30—Low-molecular-weight compounds
- C08G18/32—Polyhydroxy compounds; Polyamines; Hydroxyamines
- C08G18/3203—Polyhydroxy compounds
- C08G18/3206—Polyhydroxy compounds aliphatic
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/30—Low-molecular-weight compounds
- C08G18/38—Low-molecular-weight compounds having heteroatoms other than oxygen
- C08G18/3878—Low-molecular-weight compounds having heteroatoms other than oxygen having phosphorus
- C08G18/3889—Low-molecular-weight compounds having heteroatoms other than oxygen having phosphorus having nitrogen in addition to phosphorus
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/70—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the isocyanates or isothiocyanates used
- C08G18/72—Polyisocyanates or polyisothiocyanates
- C08G18/74—Polyisocyanates or polyisothiocyanates cyclic
- C08G18/76—Polyisocyanates or polyisothiocyanates cyclic aromatic
- C08G18/7657—Polyisocyanates or polyisothiocyanates cyclic aromatic containing two or more aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G61/00—Macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain of the macromolecule
- C08G61/02—Macromolecular compounds containing only carbon atoms in the main chain of the macromolecule, e.g. polyxylylenes
- C08G61/10—Macromolecular compounds containing only carbon atoms in the main chain of the macromolecule, e.g. polyxylylenes only aromatic carbon atoms, e.g. polyphenylenes
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/68—Polyesters containing atoms other than carbon, hydrogen and oxygen
- C08G63/692—Polyesters containing atoms other than carbon, hydrogen and oxygen containing phosphorus
- C08G63/6924—Polyesters containing atoms other than carbon, hydrogen and oxygen containing phosphorus derived from polycarboxylic acids and polyhydroxy compounds
Definitions
- the present invention relates to a novel compound having a phosphorylcholine group, a novel polymer having a phosphorylcholine group in a side chain obtained by performing a polymerization reaction using the compound as a raw material, and a method for producing the same.
- biocompatible materials have been developed to solve these problems.
- phospholipids that focus on the structure of the surface of biomembrane are one of the materials that show outstanding biocompatibility.
- a homopolymer of 2-methacryloyloxetyl phosphorylcholine (MPC), a polymer carrying a phosphorylcholine group as a polar group, or a copolymer with other monomers hereinafter simply referred to as MPC polymer. Let's go. (Ishihara et al., Polymer Journal, Vol. 22, p. 355, 1990).
- MPC is a methacrylate ester whose homopolymer is water-soluble.It can be made water-insoluble by copolymerizing with various butyl monomers, making it a suitable structure for treating medical device surfaces. be able to.
- MPC polymers are used in Europe and the United States as surface coatings for medical devices that have already been clinically applied, and devices have been approved in Japan. It is expected to dramatically improve the quality of life of patients.
- the MPC itself is hydrophilic, and the copolymer of MPC and Bull monomer is affected by the flexible main chain structure, it has heat resistance that can withstand autoclave sterilization.
- the MPC polymer is not yet perfect in terms of hydrolysis resistance and mechanical strength, while maintaining the excellent biocompatibility and processability of the above MPC polymer while maintaining heat resistance, hydrolysis resistance and mechanical strength. The emergence of improved new materials was desired. Disclosure of the invention
- the present inventors have conducted intensive studies in view of such circumstances, and as a result, synthesized a specific novel compound having a phosphorylcholine group, and carried out a polymerization reaction using the compound as a raw material to obtain mechanical strength and hydrolysis resistance.
- the present inventors have found that a novel polymer having excellent heat resistance, heat resistance, and biocompatibility can be obtained, and have completed the present invention. That is, the present invention provides a polymer having improved heat resistance, hydrolysis resistance, and mechanical strength while maintaining excellent biocompatibility and processability, a method for producing the same, and a compound as a starting material thereof. It is intended to be.
- the compound having a phosphorylcholine group according to the present invention is a compound represented by the following general formula (I).
- X 1 and X 2 are both an amino group or a group represented by C00R 1 , and R 1 may be the same or different and represents a hydrogen atom or a carboxyl protecting group;
- A represents any single bond selected from the group consisting of a single bond, one 0—, one C00—, one 00C—, —C0NH—, one NH—, —NHC0—, one dose 2— , and one CH 20 —, and
- R 2 Represents an alkyl group having 1 to 6 carbon atoms, and m represents an integer of 1 to 12.
- the compound having a phosphorylcholine group is preferably a diamine compound in which both X 1 and X 2 are amino groups.
- the compound having a phosphorylcholine group is also preferably a dicarbonic acid compound in which both X 1 and X 2 are groups represented by one C00R 1 , and both R 1 are hydrogen atoms. .
- the compound having a phosphorylcholine group is a group in which both X 1 and X 2 are represented by one C00R 1 , and R 1 may be the same or different, and an alkyl group having 1 to 6 carbon atoms It may be a substituted or unsubstituted arylmethyl group, a cyclic ether residue, an alkylsilyl group or an alkylphenylsilyl group.
- the polymer according to the present invention has a phosphorylcholine group represented by the following general formula (II): Is contained in an amount of at least 1 mol%, and has a number average molecular weight of 1,000 or more.
- a single bond, - 0-, One C00-, One 00C-, One C0NH-, One NH-, - NHC0- one NR 2 -, of any one selected from a C 0 R 2 represents an alkynole group having 1 to 6 carbon atoms, and m represents an integer of 1 to 12;
- the polymer is preferably a polymer having at least one selected from an amide bond, an ester bond, a urethane bond, a urea bond, and an imido bond in its main chain skeleton.
- the method for producing a polymer according to the present invention is characterized in that a compound having a phosphorylcholine group represented by the following general formula (I) and another polymerizable monomer are subjected to polycondensation or polyaddition reaction. .
- X 1 and X 2 are both an amino group or a group represented by C00R 1 , and R 1 may be the same or different and represents a hydrogen atom or a carboxyl protecting group;
- A represents any one bond selected from a single bond, one 0—, one C00—, one 00C—, one C0NH—, —NH—, —NHC0—, one NR 2 —, and one CH 20 — 2 represents an alkyl group having 1 to 6 carbon atoms, and m represents an integer of 1 to 12.
- the other polymerizable monomer is dicarboxylic acid, dicarboxylic acid derivative, tetraforce It is preferably at least one selected from rubonic dianhydride, diisocyanate compound, diamine compound, and diol compound.
- Fig. 1 is an electron micrograph ( ⁇ 2,000) of the surface of the PA-1 thin film after contact with human PRP.
- Figure 2 is an electron micrograph (2,000x) of the surface of the PA-2 thin film after contact with human PRP.
- Fig. 3 is an electron micrograph (2,000x) of the surface of the PA-3 thin film after contact with human PRP.
- Figure 4 is an electron micrograph ( ⁇ 2,000) of the surface of the PA-4 thin film after contact with human PRP.
- Figure 5 is an electron micrograph (2,000x) of the surface of the PA-5 thin film after contact with human PRP.
- Figure 6 is an electron micrograph ( ⁇ 2,000) of the surface of the PA-6 thin film after contact with human PRP.
- Fig. 7 is an electron micrograph (2,000x) of the surface of the PA-7 thin film after contact with human PRP.
- Figure 8 is an electron micrograph (2,000x) of the surface of the PA-8 thin film after contact with human PRP.
- Fig. 9 is an electron micrograph (2,000-fold magnification) of the surface of the PUU-1 thin film after contact with human PRP.
- Figure 10 is an electron micrograph (2,000x) of the surface of the PUU-2 thin film after contact with human PRP.
- Fig. 11 is an electron micrograph ( ⁇ 2,000) of the PUU-3 thin film surface after contact with human PRP.
- FIG. 12 is an electron micrograph ( ⁇ 2,000) of the surface of the PA-0 thin film after contact with the human PRP.
- Fig. 13 is an electron micrograph (2,000-fold magnification) of the surface of the PU-0 thin film after contact with the human PRP.
- the compound having a phosphorylcholine group according to the present invention is a compound represented by the following general formula (I).
- X 1 and X 2 are both an amino group or a group represented by C00R 1 , and R 1 may be the same or different and represents a hydrogen atom or a carboxyl protecting group;
- A is a single bond, _0—, one C00—, —00C—, one C0NH—, —NH—, —NHC0—, one NR 2 —, one CH 20 —, preferably one — Or 1 C00—,
- R 2 represents an alkyl group having 1 to 6 carbon atoms, and m represents an integer of 1 to 12 and preferably an integer of 1 to 6.
- the alkyl group having 1 to 6 carbon atoms represented by R 2 includes a methyl group, an ethyl group, a propyl group, and an isopropyl group.
- R 2 the alkyl group having 1 to 6 carbon atoms represented by R 2 includes a methyl group, an ethyl group, a propyl group, and an isopropyl group.
- R 1 when X 1 and X 2 are both groups represented by C00R 1 , that is, when the compound having a phosphorylcholine group of the present invention is a dicarboxylic acid compound, R 1 may be the same or different and represents a hydrogen atom or a protecting group for a hydroxyl group. Among them, in the present invention, it is preferable that both R 1 are hydrogen atoms or both are a carboxyl protecting group.
- the R 1 may be the same or different and may be a methyl group, an ethyl group, an isopropyl group, a butyl group, a pentyl group, a hexyl group or the like.
- Alkyl group having 1 to 6 carbon atoms benzyl group, p-methylbenzyl group, m-ethylbenzyl group, p-methoxybenzyl group, p-2-trobenzinole group, m-chlorobenzyl group, 1,4-dimer Substituted or unsubstituted arylmethyl groups such as toxicbenzinole, benzylhydryl, di (p-methoxyphenyl) methyl, and trityl; tetrahydrovinylyl, tetrahydrofuranyl, 1,4-dioxane-12 —Cyclic ether residue such as yl group; alkylsilyl group such as trimethylsilyl group, tert-butyldimethylsilyl group, tert-butyldiphenylsilyl group Or an alkylphenylsilyl group.
- the compound having a phosphorylcholine group is preferably a compound represented by the following general formula (IA).
- diamine compounds in which both X 1 and X 2 are amino groups are specifically described.
- it can be manufactured by the method described below.
- a dinitrate compound having a hydroxyl group represented by the following general formula (III) and a 2-chloro-2-oxo-1,1,3,2-dioxaphosphorane hereinafter, also referred to as COP.
- COP 2-chloro-2-oxo-1,1,3,2-dioxaphosphorane
- Can 2 together synthesize the diamine compound is an amino group.
- the dinitro compound having a hydroxyl group represented by the general formula (III) can be easily synthesized from a commercially available compound by a known reaction according to the method described in Examples 1 and 4 described below. be able to.
- the reaction of the dinitro compound of the general formula (III) with COP is carried out so that the dinitro compound (III): COP is 1: 1 to 1: 5 mol, and triethylamine or the like is used to capture the generated hydrogen chloride. It is preferable to perform the reaction while injecting an inert gas into the reaction system in order to remove hydrogen chloride from the reaction system in the presence of the tertiary amine.
- TMA trimethinoleamine
- Subsequent reduction of the nitro group is usually performed with reductions such as diborane, lithium borohydride, sodium borohydride, sodium aluminum hydride, dialkoxy aluminum hydride, sodium getyl aluminum hydride, etc. It proceeds easily by reacting with an agent. In this case, the reaction suitably proceeds by performing the reaction in the presence of a catalyst such as tin chloride. In addition, hydrogen gas It is also possible to carry out catalytic reduction using a metal such as nickel, platinum, palladium or rhodium as a catalyst under a sulfur atmosphere.
- reaction temperature ranges from 100 ° C. to 150 ° C., preferably from 150 ° C. to 100 ° C.
- a dicarboxylic acid conjugate in which X 1 and X 2 are both groups represented by —C00R 1 (hereinafter simply referred to as the dicarboxylic acid conjugate of the present invention) Specifically, it can be produced, for example, by the method described below.
- the dicarboxylic acid conjugate of the present invention can be synthesized.
- R 1 may be the same or different, and Represents a protecting group for a substituent or a carboxyl group, and A and m are the same as defined in the general formula (I).
- the dicarboxylic acid compound having a hydroxyl group represented by the general formula (VI) can be easily synthesized from a commercially available compound by a known reaction according to the method described in Examples 2 and 3 described below. can do.
- reaction between the compound (VI) and COP, the charge ratio of the next ring-opening addition reaction between the compound (VII) and TMA, the reaction conditions, and the like are the same as those in the above-described production of the diamine compound. .
- a dicarboxylic acid compound in which X 1 and X 2 in the general formula (I) are both C00R 1 and R 1 is a carboxyl group-protecting group by the method described above. That is, it can be obtained by synthesizing a compound represented by the following general formula ( ⁇ - ⁇ ) and substituting the protecting group R 3 of this dicarbonic acid compound (I-I) with a hydrogen atom by an appropriate deprotection reaction. it can.
- R 3 represents a carboxyl-protecting group
- a and m are the same as defined in the general formula (I).
- the carboxyl-protecting group represented by R 1 or R 3 is stably present in the above reaction, and is a deprotection reaction.
- those which can be removed without damaging other parts are selected.
- the carboxyl-protecting group that satisfies this requirement the above-mentioned one having 1 to carbon atoms Preferred are an alkyl group, substituted or unsubstituted arylmethyl group, a cyclic ether residue, an alkylsilyl group or an alkylfuelsilyl group, and the carboxyl-protecting group described above can be prepared by a known method (for example, TW Greene , P. Lr. M. Wuts, Protective Groups in Organic Synthesis, Third Edition, John Wiley & Sons, New York, 1999, p. 372-431). .
- the deprotection reaction can be performed by a known method depending on the type of protecting group used (for example, TW Greene, PGM Wuts, "Protective Groups in Organic Synthesis, Third Edition", John Wiley & Sons, New York, 1999, pp. 372-431).
- the polymer according to the present invention contains a repeating unit having a phosphorylcholine group represented by the following general formula ( ⁇ ) in an amount of at least 1 mol%, and has a number average molecular weight of 1,000 or more. .
- polymer is used in a broad sense including a homopolymer and a copolymer, and in the case of a copolymer, a random copolymer, a block copolymer, Any of graft copolymers may be used.
- the number average molecular weight of the polymer is usually 1,000 or more, preferably 5,000 or more. Above, more preferably in the range of 10,000 to 500,000 in terms of mechanical strength, heat resistance and stability. The number average molecular weight is measured by gel permeation chromatography in terms of polystyrene.
- the polymer it is necessary for the polymer to contain a repeating unit having a phosphorylcholine group represented by the general formula (II) in an amount of at least 1 mol% in order to exhibit biocompatible regeneration. If it is necessary to impart more excellent biocompatibility, it is desirable that the content be 5 mol% or more, more preferably 5 to 50 mol%.
- the content of the repeating unit having a phosphorylcholine group represented by the general formula (II) in the polymer controls the charge ratio of the compound having a phosphorylcholine group of the present invention used as a raw material monomer in a polymerization reaction described later. Can be easily controlled.
- the repeating unit having a phosphorylcholine group is specifically preferably a repeating unit represented by the following general formula (II-A).
- the polymer preferably has at least one selected from an amide bond, an ester bond, a urethane bond, a urea bond, and an imido bond in its main chain skeleton.
- the polymer of the present invention has a phosphorylcholine group represented by the general formula (I).
- the compound can be produced by subjecting a compound as a starting monomer to a usual polycondensation or polyaddition reaction with another polymerizable monomer.
- the term "other polymerizable monomer” refers to a monomer other than the compound having a phosphorylcholine group represented by the general formula (I) and a monomer that can be polymerized with the compound.
- examples of the other polymerizable monomer include dicarboxylic acid, dicarboxylic acid derivative, tetracarboxylic dianhydride, diisocyanate compound, diamine compound, and diol compound. It is preferable to use
- the amount of Jiamin compounds of the present invention is 1 molar 0/0 or more, preferably 5 mol 0/0 or more, more preferably 5 to 5 0 mol% It is desirable to use a mixture in such a range that the biocompatibility of the polymer is exhibited.
- the dicarboxylic acid and dicarbonic acid derivative used as the other polymerizable monomer are represented by the following general formula (XI)
- the repeating unit of the obtained polyamide that is, the repeating unit containing the structural unit represented by the general formula ( ⁇ ) in the polymer of the present invention is represented by the following general formula (XII)
- Y 1 represents a divalent organic group
- a and m each represent the same as defined in the general formula (I).
- dicarboxylic acid represented by the general formula (XI) include phthalic acid, terephthalanolic acid, isophthalic acid, 2,6-naphthalenedicanoleponic acid, 1,6-naphthalenedicarboxylic acid, and 2,6_ Anthracene dicarboxylic acid, 1,6-anthracene dicanolevonic acid, 4,4,1-biphenyldicarboxylic acid, 4,4'diphenylmethanedicarboxylic acid, 4,4, diphenyletherdicarboxylic acid, 2,2'-bis ( 4-monocarboxylphenyl) propane, 2,2,1-bis (4-carboxy) (Sifenoxyphenyl) propane, oxalic acid, fumanoleic acid, maleic acid, malonic acid, succinic acid, daltaric acid, adipic acid, pimelic acid, suberic acid, azelaic acid, sepasic acid, 1,9-n
- the tetracarboxylic dianhydride used as the other polymerizable monomer is represented by the following general formula (XIII)
- Y 2 represents a tetravalent organic group
- a and m each represent the same as defined in the general formula (I).
- tetracarboxylic dianhydride represented by the general formula ( ⁇ ) for example, pyromellitic dianhydride, 2,3,6,7-naphthalenetetracarboxylic dianhydride, 1,2,5,6-naphthalenetetracarboxylic dianhydride, 1,4,5,8-naphthalenetetraanhydride Carboxylic acid dianhydride, 2,3,6,7-anthracene dianhydride, 1,2,5,6-anthracenetetracarboxylic dianhydride, 3,3 ', 4,4'-diphene -L-tetracarboxylic dianhydride, bis (3,4-dicanololeboxyphenole) athenoleni anhydride, 3,3 ', 4,4'-benzophenonetetracarboxylic dianhydride, bis (3 , 4-Dicarboxyphenyl) sulfone dianhydride, bis (3,4-dicarboxyphenyl)
- the diisocyanate compound used as the other polymerizable monomer has the following general formula (XV)
- diisocyanate compound represented by the general formula (XV) include 1,4-phenylene diisocyanate, 1,3-phenylene diisocyanate, and 1,4-xylene diisocyanate 1,3-xylylene diisocyanate, 2,4-toluylene diisocyanate, 2,5-toluylene diisocyanate, 4,4'-biphenylenediocyanate, 4, 4 'diphenyl ether diisocyanate, 4, 4' diphenyl methane diisocyanate, 4, 4 '-(2,2-diphenylpropane) diisocyanate, tetramethylene diisocyanate, Pentamethylene diisocyanate, hexamethylene diisocyanate, heptamethylenediisocyanate, otatamethylene diisocyanate, etc. These may be used alone or in combination of two or more. It is possible to use.
- the amount of the dicarboxylic acid conjugate of the present invention is 1 mol% or more, preferably 5 mol% or more, more preferably 5 to 50 mol%, based on the total amount of the dicarboxylic acid compound used. It is desirable to use a mixture in such a range as to exhibit the biocompatibility of the polymer.
- the obtained polymer for example, by polymerizing a diisocyanate compound and a diol compound, by adding the dicarponic acid compound of the present invention, It is also possible to produce a poly (urethane monoester) having a urethane bond and an ester bond in the main chain skeleton.
- the diamine compound used as the other polymerizable monomer has the following general formula
- Y 4 represents a divalent organic group
- a and m each represent the same as defined in the general formula (I).
- Specific examples of the diamine compound represented by the general formula (XVII) include 1,4-phenylenediamine, 1,3-phenylenediamine, 2,5-diaminoto / reene, 2,6-diaminotoluene, 4,4'-diaminobiphenyl, 3,3'-dimethinole 4,4'diaminobiphenyl, 3,3'-dimethoxy-1,4,4'-diaminobiphenyl, 4,4'-diaminodiphenylmethane, 4,4'-Diamino-3,3'-Dimethyldiphenylmethane, 4,4'Diaminodiphenylethenole, 2,2'-Bis (4-aminophenyl) propane, 4,4'Diaminodiphenylsulfone, 4, 4, Diaminobenzophenone,
- the diol compound used as the other polymerizable monomer has the following general formula (XIX)
- Upsilon 5 represents a divalent organic group
- A, m represents the same thing as is respectively defined in the general formula (I).
- diol compound represented by the general formula (XIX) examples include hydroquino
- the polycondensation or polyaddition reaction using the compound having a phosphorylcholine group represented by the general formula (I) and another polymerizable monomer is carried out by a method known in the literature (for example, JA Moore, edited by Macromolecular Synthesis, John Wiley & Sons, New York, 04 001794
- the compound having a phosphorylcholine group of the present invention a novel polymer having a phosphorylcholine group in a side chain can be easily synthesized. Further, the polymer of the present invention has good moldability and excellent heat resistance, hydrolysis resistance, mechanical strength and biocompatibility. Therefore, by using the polymer as a material, it is possible to produce human organs such as artificial blood vessels and various medical devices having excellent heat resistance, hydrolysis resistance, mechanical strength, and biocompatibility. It becomes.
- ethylene glycol (24.0 ml, 430 mmol), dry tetrahydrofuran (O ml), and dry triethylamine (60.0 ml) were mixed in a three-neck flask to obtain a solution obtained by mixing 3,5-di-tro.
- a solution of benzoyl chloride (10.0 g, 43.4 t) dissolved in dry tetrahydrofuran (150 ml) was slowly dropped in an ice-water bath.
- the compound (6) obtained in the above reaction (3.00 g, 11.8 mmol), dry tetrahydrofuran (60 ml), and dry triethylamine (3.40 ml) were mixed in a triple flask, and the mixture was placed in an ice-water bath. While stirring, 2-chloro-2-oxo-1,3, 2-Dioxaphospholane (2.12 ml, 23.6 mmol) was slowly added dropwise. After completion of the dropwise addition, the mixture was stirred at room temperature for 2 hours, and the precipitate was filtered by suction.
- the obtained precipitate is dissolved in chloroform, washed with distilled water, the organic phase is dehydrated with sodium sulfate, filtered, and the solvent is distilled off under reduced pressure, and represented by the above formula (7).
- the phosphorane compound was obtained as a white solid (yield: 2.00 g, 46.7%).
- the structure of this compound was confirmed from the following I-band R spectrum.
- the compound (7) (1.50 g, 4.16 mmol) obtained in the above reaction was dissolved in dry acetonitrile (20.0 ml) in an eggplant-shaped flask, and trimethyl chloride was added to this solution in a 130 ° C refrigerant bath. (0.50 ml, 5.47 mmol), the vessel was sealed and reacted at 60 ° C. overnight. Next, the solvent was distilled off under reduced pressure, concentrated, and cooled in a refrigerant bath, whereby a precipitate was formed.
- Example 2 The compound (6) (3.40 g, 15.8 mmol) obtained in Example 2 was dissolved in 64 ml of tetrahydrofuran, 50 ml of an aqueous solution containing 3.74 g of sodium hydroxide was added to this solution, and the mixture was refluxed for 72 hours. Next, the reaction solution was cooled to room temperature, concentrated hydrochloric acid was added until the pH reached about 1 to 2, tetrahydrofuran was distilled off under reduced pressure, and excess distilled water was added and left.
- the compound (10) (1.30 g, 3.91 ramol) obtained in the above reaction was dissolved in dry acetonitrile (30.0 ml) in an eggplant-shaped flask, and trimethyl chloride was added to this solution in a 30 ° C refrigerant bath. Add the amine (0.50 ml, 5.47 ramol) and seal the container. The reaction was performed with C. Next, the solvent was distilled off under reduced pressure, concentrated, and cooled in a refrigerant bath, whereby a precipitate was formed.
- the compound (12) (2.00 g, 7.04 mmol) obtained by the above reaction, dry tetrahydrofuran (15.0 ml), and dry triethylamine (4.00 ml) were mixed in three ports.
- the mixture was mixed in a flask, and 2-chloro-1-oxo-1,3,3-dioxaphospholane (0.970 ml, 10.6 mmol) was slowly added dropwise while stirring in an ice water bath. After completion of the dropwise addition, the mixture was stirred at room temperature for 2 hours, and the precipitate was filtered by suction.
- IR, v (KBr neat, era “ 1 ): 3108, 2964, 1715, 1628, 1553, 1470, 1352, 1290, 1180, 1109, 1047, 935, 833, 779, 584.
- the compound (13) (7.22 g, 18.5 mmol) obtained in the above reaction was dissolved in dry acetonitrile (100 ml) in an eggplant-shaped flask, and the solution was added to the solution in a 30 ° C refrigerant bath. Trimethylamine (3.44 ml, 37.0 mmol) was added, the vessel was sealed and reacted at 60 ° C. overnight. Next, the solvent was distilled off under reduced pressure, concentrated, and cooled in a refrigerant bath, whereby a precipitate was formed.
- the polymer was precipitated by pouring the reaction solution into excess ethanol, filtered, and dried under reduced pressure, to obtain 2.02 g of a polyamide copolymer having a phosphorylcholine group represented by the above formula PA-1. Obtained as a light brown powder. The structure was confirmed from the following 1 H—band R spectrum.
- composition ratio x / y of PA-1 determined from the peak area ratio of the NMR spectrum was 91/9.
- molecular weight of PA-1 was measured by gel permeation chromatography (standard substance: polystyrene) using dimethylformamide as a solvent, the number average molecular weight and the weight average molecular weight were 5.50 ⁇ 10 3 and 1.91 ⁇ 10 4 , respectively.
- the glass transition temperature (softening temperature) of PA-1 determined by differential scanning calorimetry was about 215 ° C, indicating sufficient heat resistance for use in medical devices.
- the obtained copolymer PA-1 is soluble in aprotic polar solvents such as N-methylpyrrolidinone, dimethylformamide, and dimethylsulfoxide, and is soluble in water, methanol, ethanenore, chlorohonolem, acetoneton, tetrahydrofuran, and ⁇ . Insoluble in tarilonitrile.
- aprotic polar solvents such as N-methylpyrrolidinone, dimethylformamide, and dimethylsulfoxide
- composition ratio x / y of PA-2 determined from the peak area ratio of the paper R spectrum was 86/14.
- PA- molecular weight of 2 to a dimethylformamide solvent was Gerupami er Chillon chromatography (standard: polystyrene) and was measured by rollers, each of the number average molecular weight and weight-average molecular weight 5.
- the glass transition temperature (softening temperature) of PA-2 determined by differential scanning calorimetry was about 180 ° C, and PA_2 showed the same solubility as PA-1.
- Example 5 Using 35 isophthalic acid chloride (0.60 g, 2.96 mmol) and dry N-methylpyrrolidinone (5.9 ml), the same operation as in the polymerization reaction and purification shown in Example 5 was carried out. 1.02 g of a polyamide copolymer (PA-3) having a phosphorylcholine group represented by the same formula as above was obtained as a light brown powder. The 1 H-NMR spectrum of PA-3 obtained here was the same as the spectrum result of PA-1 shown in Example 5.
- PA-3 polyamide copolymer having a phosphorylcholine group represented by the same formula as above
- composition ratio x / y of PA-3 determined from the peak area ratio of the Bandai R spectrum was 80/20.
- PA- 3 of molecular weight Gerupami er Chillon chromatography of dimethylformamide ⁇ bromide as a solvent (standard substance: polystyrene) and roller was measured by, met a number average molecular weight and weight-average molecular weight, respectively 4.11X10 3 and 6.19 X 10 3 Was.
- the glass transition temperature (softening temperature) of PA-3 determined by differential scanning calorimetry was about 152 ° C, and PA-3 showed the same solubility as PA-1.
- composition ratio x / y of PA-4 determined from the peak area ratio of the NMR-NMR spectrum was 50/50.
- molecular weight of PA-4 was measured by gel permeation chromatography (standard substance: polystyrene) using dimethylformamide as a solvent, the number average molecular weight and weight average molecular weight were 5.25 ⁇ 10 3 and 1.43 ⁇ 10, respectively.
- the glass transition temperature (softening temperature) of PA-4 determined by differential scanning calorimetry was about 150 ° C, and PA-4 exhibited the same melting angle as PA-1.
- the compound (11) (0.150 g, 0.384 mmol), 4,4, diamino-1,3,3,1-dimethinoresifeninolemethane (0.174 g) obtained by the production method shown in Example 3 was obtained.
- 0.768 bandol) and isophthalic acid (0.0637 g, 0.383 mmol) were mixed in an eggplant flask, and dried N-methylpyrrolidinone (1.53 ml), pyridine (0.12 ml) and triphenyl phosphite (0.40 ml) were added. After addition to form a solution, the solution was stirred at 80 QC for 24 hours.
- composition ratio x / y of PA-5 determined from the peak area ratio of the 3 ⁇ 4_NMR spectrum was 78/22.
- PA- molecular weight of 5 to the dimethylformamidine de and the solvent was Gerupami er Chillon chromatography (standard substance. 'Polystyrene) and roller was measured by the number average molecular weight and weight-average molecular weight, respectively 1.04X10 4 and 3.91 X 10 4 there were.
- the glass transition temperature (softening temperature) of PA-5 determined by differential scanning calorimetry was about 180 ° C, and PA-5 showed the same solubility as PA-1.
- the compound (4) (0.20 g, 0.55 mmol) obtained by the production method shown in Example 1 and 4,4′-diamino-1,3,3′-dimethyldiphenylmethane (1, 12 g, 4.95 mmol) and isophthalic acid (0.91 g, 5.50 mraol) were mixed in an eggplant flask, and dried N-methylpyrrolidinone (10.0 ml), pyridine (2.90 ml) and trifenyl phosphite (0.88 ml) were added to the solution. After that, the solution was stirred at 100 ° C for 24 hours.
- the reaction solution is cooled to room temperature and poured into an excess of methanol to precipitate a polymer.
- the polymer is dried under reduced pressure, and the copolymer having a phosphorylcholine group represented by the above formula PA_6 is copolymerized. 1.77 g of the combined product was obtained as a light brown powder.
- the structure was confirmed from the following one band R spectrum.
- composition ratio m / n of PA-6 determined from the peak area ratio of the Ichiran R spectrum was 98/2.
- the molecular weight of PA-6 was measured by gel permeation chromatography (standard substance: polystyrene) using dimethylformamide as a solvent, the number average molecular weight and weight average molecular weight were 1.52 ⁇ 10 4 and 6.48 ⁇ , respectively. It was 10 4 .
- the glass transition temperature (softening temperature) of PA-6 determined by differential scanning calorimetry is about 205 ° C. It showed the same solubility as VIII-1.
- the compound (4) (0.10 g, 0.28 mmol), 2,2′-bis (4-aminophenoxypheninole) propane (1.02 g, 2.49 ol), 2,2,1-bis (4-carboxyphenoxyphenyl) prono ,. (1.30 g, 2.77 mmol) were mixed in an eggplant-shaped flask, and dried N-methylpyrrolidinone (5.00 ml), pyridine (0.44 ml) and triphenylphosphine (1.50 ml) were added to form a solution. The solution was stirred at 100 ° C for 24 hours. Next, the reaction solution is cooled to room temperature and poured into an excess of methanol to precipitate a polymer.
- the polymer After filtration, the polymer is dried under reduced pressure, and the polyamide having a phosphorylcholine group represented by the above formula PA-7 is obtained. 2.24 g of the copolymer was obtained as a light brown powder. In addition, the structure was confirmed from the following 3 ⁇ 4-band R spectrum.
- composition ratio m / n of PA-7 determined from the peak area ratio of the 3 ⁇ 4-thigh R spectrum was 95/5.
- PA- 7 Gerupami er Chillon chromatography the molecular weight was dimethylformamidine de and solvent (standard: polystyrene) and was measured by rollers, the number average molecular weight and weight-average molecular weight in each 1.44X 10 4 and 3.39 X 10 4 there were.
- the glass transition temperature (softening temperature) of PA-7 determined by differential scanning calorimetry was about 175 ° C, and PA-7 showed the same solubility as PA-1.
- the copolymer PA-7 was dissolved in dimethylformamide, and a robust film was produced by the solvent casting method.
- the reaction solution is cooled to room temperature and poured into an excessive amount of methanol to precipitate a polymer.
- the polymer is dried under reduced pressure, and the copolymer having a phosphorylcholine group represented by the above formula PA-8 is copolymerized. 2.24 g of the compound were obtained as a light brown powder. The structure was confirmed from the following 1 H-NMR spectrum.
- composition ratio m / n of PA-8 determined from the peak area ratio of 3 ⁇ 4—Ran R Stattle was 85/15.
- molecular weight of PA-8 was measured by gel permeation chromatography (standard substance: polystyrene) using dimethylformamide as a solvent, the number average molecular weight and weight average molecular weight were 2.17 ⁇ 10 4 and 2. It was a 93 X 10 4.
- the glass transition temperature (softening temperature) of PA-8 determined by differential scanning calorimetry was about 150 ° C., and PA-8 showed the same solubility as PA-1.
- the copolymer PA-8 was dissolved in dimethylformamide, and a strong film could be produced by the solvent casting method.
- the average degree of polymerization of the polyurethane segment of PUU-1 determined from the peak area ratio of the NMR spectrum was about 9.
- the molecular weight of P UU-1 was measured by gel permeation chromatography (standard substance: polystyrene) using dimethylformamide as a solvent.
- the number average molecular weight and weight average molecular weight were 3.60 ⁇ 10 4 and 1.50 ⁇ 10 5 , respectively. .
- the glass transition temperature (softening temperature) of PUU-1 is not observed in the temperature range from room temperature to 300 ° C, and is considered to be 300 ° C or higher. It showed sufficient heat resistance to be used for devices.
- PUU-1 is soluble in aprotic polar solvents such as N-methylpyrrolidinone, dimethylformamide, and dimethylsulfoxide. Insoluble in toril. Such solubility of PUU-1 is insoluble in a specific solvent, so it is advantageous when performing molding processing for materialization such as coating or hollow fiber formation, while it is suitable for many solvents. This is advantageous in that since it is insoluble, it can be made into a highly durable device after being made into a material.
- aprotic polar solvents such as N-methylpyrrolidinone, dimethylformamide, and dimethylsulfoxide.
- Such solubility of PUU-1 is insoluble in a specific solvent, so it is advantageous when performing molding processing for materialization such as coating or hollow fiber formation, while it is suitable for many solvents. This is advantageous in that since it is insoluble, it can be made into a highly durable device after being made into a material.
- 1,4-butanediol (0.30 ml, 3.32 armol) and triethylamine (0.2 ml) were dissolved in dry N-methylpyrrolidinone (5.0 ml) in a three-neck flask.
- the content of phosphorylcholine unit in PUU-2 determined from the peak area ratio of the 3 ⁇ 4-NMR spectrum was 5 mol%.
- the molecular weight of PUU-2 was measured by gel permeation chromatography (standard substance: polystyrene) using dimethylformamide as a solvent, the number average molecular weight and weight average molecular weight were 1.06 ⁇ 10 4 and 1.71 ⁇ 10 4 , respectively.
- the glass transition temperature (softening temperature) of PU U-2 was not observed in the temperature range from room temperature to 300 ° C, and PUU-2 showed the same solubility as PUU-1. .
- ethylene glycol (0.44 ml, 7.99 tmol), 4,4'-diphenylmethane diisocyanate (2.62 g, 9.59 mmol) and dibutyltin dilaurate (0.2 ml) were dried in a three-neck flask.
- the solution was dissolved in methylpyrrolidinone (16 ml), and the solution was stirred at 50 ° C. for 2.5 hours.
- a solution of polyethylene glycol (molecular weight: 1,000, 0.80 g, 0.799 mmol) dissolved in dry N-methylpyrrolidinone (8 ml) was slowly added dropwise to the reaction solution at 50 ° C.
- 3 ⁇ 4- ⁇ R, ⁇ 400 MHz, DMS0- d 6, ppm: 3.30 (s, N_CH 3), 3.60 (m, - CH 2 one), 3.79 (s, -CH 2 -), 4.12 (m, One CH 2 —), 4.30 (s, one CH 2 —), 4.95 (m, one CH 2 —), 6.61 (m, one Ph—), 6.90 (m, _Ph—), 7.06 (d, one Ph— ), 7.35 (d, — Ph—), 9.60 (bs, -NH-).
- the content of phosphorylcholine unit in PUU-3 determined from the peak area ratio of the paper R spectrum was 7.3 mol%.
- the glass transition temperature (softening temperature) of PUU-3 was not observed in the temperature range from room temperature to 200 ° C, and PUU-3 showed the same solubility as PUU-1.
- Polymers obtained in Examples 5 to 15 PA-1, PA-2, PA-3, PA-4, PA-5, PA-6, PA-7, PA-8, PUU-1, PUU-2, And PUU-3 were dissolved in dimethylformamide to give a concentration of 1.5% by weight.
- a polyethylene terephthalate (PET) substrate (diameter: 14 mm, thickness: 0.2 ram) was immersed in 5 ml of these solutions at room temperature for 2 hours to form a polymer thin film on the surface of the PET substrate.
- the platelet was immersed in 2 ml of the human platelet-rich plasma (PRP) at 37 ° C for 3 hours.
- PA- 0 molecular weight of dimethyl formamidine de gel permeation for business purposes chromatography was a solvent was measured by, respectively, the number-average molecular weight Contact Yopi weight average molecular weight 1.02x10 4 and 3.12X10 4 It was.
- the glass transition temperature (softening temperature) of PA-0 determined by differential scanning calorimetry is The temperature was about 190 ° C, and PA-0 showed the same solubility as PA-1.
- a polyethylene terephthalate (PET) substrate (diameter: 14 mm, thickness: 0.2 thigh) was placed at room temperature in 5 ml of a solution of the obtained polymer PA-0 in dimethylformamide at a concentration of 1.5% by weight. The polymer was immersed for 2 hours to form a polymer thin film on the PET substrate surface.
- the PET substrate coated with this polymer thin film was subjected to a blood contact test by the method described in the above test example, and the surface of the polymer thin film was observed using a scanning electron microscope.
- Figure 12 shows the results.
- PU- 0 molecular weight of the dimethyl formamide solvent gel permeation for business purposes chromatography was measured by the number-average molecular weight and weight-average molecular weight was filed respectively 5.24X10 4 and 8.65X10 4.
- glass transition temperature (softening temperature) of PU_0 was not observed in the temperature range from room temperature to 300 ° C, and PU-0 showed the same solubility as PUU-1.
- PET substrate (diameter: 14 mm, thickness: 0.2 mm) was placed at room temperature in 5 ml of a solution of the obtained polymer PU-0 in dimethylformamide at a concentration of 1.5% by weight. The polymer was immersed for 2 hours to form a polymer thin film on the PET substrate surface. The PET substrate coated with this polymer thin film was subjected to a blood contact test by the method described in the above test example, and the surface of the polymer thin film was observed using a scanning electron microscope. Figure 13 shows the results.
- the polymer of the present invention has excellent antithrombotic properties and has low adsorptivity for biological components such as proteins! / Because it is a biocompatible material, artificial organs such as artificial blood vessels and various medical devices Useful in the field of vice.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Polyamides (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
- Materials For Medical Uses (AREA)
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE602004029319T DE602004029319D1 (de) | 2003-02-18 | 2004-02-18 | Verbindung mit phoshorylcholingruppe, dessen polymer und verfahren zu dessen herstellung |
US10/518,462 US7378538B2 (en) | 2003-02-18 | 2004-02-18 | Compound having phosphorylcholine group, polymer thereof and process for producing the same |
JP2005502733A JP4628951B2 (ja) | 2003-02-18 | 2004-02-18 | ホスホリルコリン基を有する化合物、その重合体ならびにその製造方法 |
EP04712183A EP1528063B1 (en) | 2003-02-18 | 2004-02-18 | Compound having phosphorylcholine group, polymer thereof, and process for producing the same |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003040154 | 2003-02-18 | ||
JP2003-040154 | 2003-02-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004074298A1 true WO2004074298A1 (ja) | 2004-09-02 |
Family
ID=32905202
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/001794 WO2004074298A1 (ja) | 2003-02-18 | 2004-02-18 | ホスホリルコリン基を有する化合物、その重合体ならびにその製造方法 |
Country Status (5)
Country | Link |
---|---|
US (1) | US7378538B2 (ja) |
EP (1) | EP1528063B1 (ja) |
JP (1) | JP4628951B2 (ja) |
DE (1) | DE602004029319D1 (ja) |
WO (1) | WO2004074298A1 (ja) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008029744A1 (fr) | 2006-09-01 | 2008-03-13 | Tokai University Educational System | Composé diamine ayant un groupe phosphorylcholine, polymère de celui-ci et procédé servant à produire celui-ci |
JP2015506914A (ja) * | 2011-12-08 | 2015-03-05 | イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニーE.I.Du Pont De Nemours And Company | (ホスホニル)芳香族ジエステルおよび酸の調製 |
WO2016060096A1 (ja) * | 2014-10-15 | 2016-04-21 | 日油株式会社 | ホスホリルコリン基含有化合物およびホスホリルコリン複合体 |
US9598544B2 (en) | 2005-08-25 | 2017-03-21 | University Of Washington Through Its Center For Commercialization | Particles coated with zwitterionic polymers comprising sulfobetaine or carboxybetaine |
WO2018174111A1 (ja) | 2017-03-24 | 2018-09-27 | ナガセケムテックス株式会社 | スルホベタイン基含有反応性化合物、その重合体、及び重合体の製造方法 |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4191225B2 (ja) * | 2007-01-18 | 2008-12-03 | 株式会社資生堂 | 表面改質方法及び表面改質材料 |
GB201313423D0 (en) * | 2013-07-26 | 2013-09-11 | Innospec Ltd | Compositions and methods |
CN106565771B (zh) * | 2016-11-10 | 2020-05-29 | 山东师范大学 | 一种含有双氨基的磷酰胆碱化合物Lys-PC及其制备方法 |
CN106565772A (zh) * | 2016-11-10 | 2017-04-19 | 山东师范大学 | 一种新型双氨基的磷酰胆碱化合物Lys‑EG‑PC及其制备方法 |
CN106589290B (zh) * | 2016-12-28 | 2019-06-28 | 山东师范大学 | 一种高生物相容性磷酰胆碱改性聚氨酯材料及其制备方法 |
CN106674486B (zh) * | 2016-12-28 | 2019-09-24 | 山东师范大学 | 一种侧链含磷酰胆碱基团的聚酯型聚氨酯材料及其制备方法 |
CN106674484B (zh) * | 2016-12-28 | 2019-09-24 | 山东师范大学 | 一种侧链含磷酰胆碱基团聚醚型聚氨酯材料及其制备方法 |
CN107216435B (zh) * | 2017-06-26 | 2020-01-31 | 山东师范大学 | 一种侧链为磷脂化聚乙二醇的聚(氨酯-脲)及其制备方法 |
CN114213615B (zh) * | 2021-12-29 | 2022-09-16 | 广东粤港澳大湾区黄埔材料研究院 | 一种耐溶胀的磷酰胆碱改性聚氨酯材料及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993001221A1 (en) | 1991-07-05 | 1993-01-21 | Biocompatibles Limited | Polymeric surface coatings |
EP0574355A1 (en) * | 1992-06-11 | 1993-12-15 | Sandoz Ltd. | Phosphinyloxy propanaminium inner salt derivatives |
EP0767212A1 (en) * | 1995-04-03 | 1997-04-09 | Japan Science and Technology Corporation | Process for producing an aqueous solution of phosphorylcholine group bearing polymer and aqueous solution of phosphorylcholine group bearing polymer |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9004881D0 (en) * | 1990-03-05 | 1990-05-02 | Biocompatibles Ltd | Method of improving the ocular of synthetic polymers haemo and biocompatibility |
EP0913416B1 (en) * | 1997-04-17 | 2005-10-19 | Toyobo Co., Ltd. | Biocompatible polymers |
-
2004
- 2004-02-18 DE DE602004029319T patent/DE602004029319D1/de not_active Expired - Lifetime
- 2004-02-18 JP JP2005502733A patent/JP4628951B2/ja not_active Expired - Lifetime
- 2004-02-18 WO PCT/JP2004/001794 patent/WO2004074298A1/ja active Application Filing
- 2004-02-18 EP EP04712183A patent/EP1528063B1/en not_active Expired - Lifetime
- 2004-02-18 US US10/518,462 patent/US7378538B2/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993001221A1 (en) | 1991-07-05 | 1993-01-21 | Biocompatibles Limited | Polymeric surface coatings |
EP0574355A1 (en) * | 1992-06-11 | 1993-12-15 | Sandoz Ltd. | Phosphinyloxy propanaminium inner salt derivatives |
EP0767212A1 (en) * | 1995-04-03 | 1997-04-09 | Japan Science and Technology Corporation | Process for producing an aqueous solution of phosphorylcholine group bearing polymer and aqueous solution of phosphorylcholine group bearing polymer |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9598544B2 (en) | 2005-08-25 | 2017-03-21 | University Of Washington Through Its Center For Commercialization | Particles coated with zwitterionic polymers comprising sulfobetaine or carboxybetaine |
WO2008029744A1 (fr) | 2006-09-01 | 2008-03-13 | Tokai University Educational System | Composé diamine ayant un groupe phosphorylcholine, polymère de celui-ci et procédé servant à produire celui-ci |
US8063238B2 (en) | 2006-09-01 | 2011-11-22 | Tokai University Educational System | Diamine compound having phosphorylcholine group, polymer thereof, and process for producing the polymer |
JP5276443B2 (ja) * | 2006-09-01 | 2013-08-28 | 学校法人東海大学 | ホスホリルコリン基を有するジアミン化合物、その重合体ならびに製造方法 |
JP2015506914A (ja) * | 2011-12-08 | 2015-03-05 | イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニーE.I.Du Pont De Nemours And Company | (ホスホニル)芳香族ジエステルおよび酸の調製 |
WO2016060096A1 (ja) * | 2014-10-15 | 2016-04-21 | 日油株式会社 | ホスホリルコリン基含有化合物およびホスホリルコリン複合体 |
US9850266B2 (en) | 2014-10-15 | 2017-12-26 | Nof Corporation | Phosphorylcholine group-containing compound and phosphorylcholine complex |
WO2018174111A1 (ja) | 2017-03-24 | 2018-09-27 | ナガセケムテックス株式会社 | スルホベタイン基含有反応性化合物、その重合体、及び重合体の製造方法 |
JP2018162216A (ja) * | 2017-03-24 | 2018-10-18 | ナガセケムテックス株式会社 | スルホベタイン基含有反応性化合物、その重合体、及び重合体の製造方法 |
US11434322B2 (en) | 2017-03-24 | 2022-09-06 | Nagase Chemtex Corporation | Sulfobetaine group-comprising reactive compound, polymer thereof, and method of producing the polymer |
Also Published As
Publication number | Publication date |
---|---|
US20060041160A1 (en) | 2006-02-23 |
DE602004029319D1 (de) | 2010-11-11 |
JP4628951B2 (ja) | 2011-02-09 |
EP1528063A4 (en) | 2006-11-15 |
JPWO2004074298A1 (ja) | 2006-06-01 |
EP1528063A1 (en) | 2005-05-04 |
US7378538B2 (en) | 2008-05-27 |
EP1528063B1 (en) | 2010-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7301401B2 (ja) | 自立非汚染性ポリマー、それらの組成物、および関連モノマー | |
WO2004074298A1 (ja) | ホスホリルコリン基を有する化合物、その重合体ならびにその製造方法 | |
US6120491A (en) | Biodegradable, anionic polymers derived from the amino acid L-tyrosine | |
JP5276443B2 (ja) | ホスホリルコリン基を有するジアミン化合物、その重合体ならびに製造方法 | |
JP2015061901A (ja) | ホスホリルコリン基を有する重合体からなるナノシート分散液 | |
JP2698774B2 (ja) | ポリ(イミド−アミド酸エステル)及びその製造方法並びにそれを用いたポリイミド、ポリイミドフィルム、ポリイミドファイバー及びそれらの製造方法 | |
JP4315544B2 (ja) | 共重合体、その製造法、医療用材料及び眼科用材料 | |
JP2011162522A (ja) | ホスホリルコリン基を有するジオール化合物および重合体 | |
Parzuchowski et al. | Hyperbranched polyglycerols containing amine groups—Synthesis, characterization and carbon dioxide capture | |
EP3604275B1 (en) | Sulfobetaine-group-containing reactive compound, polymer thereof, and method for producing polymer | |
JPS6260416B2 (ja) | ||
Srividhya et al. | Synthesis of novel soluble poly (imide-siloxane) s via hydrosilylation: characterization and structure property behaviour | |
KR101828825B1 (ko) | 세포막-모방 브러쉬 고분자 및 그 제조방법 | |
Nagase et al. | Synthesis and properties of segmented poly (urethane-urea) s containing phosphorylcholine moiety in the side-chain | |
WO2008007629A1 (fr) | Acide polyamique et polyimide | |
JP2001520691A (ja) | ジアミンおよびテトラカルボン酸の二酸ジエステルからポリイミドを製造する方法 | |
KR20100078325A (ko) | 퓨린 미믹을 브러쉬 말단으로 가지는 자기조립성 고분자 및그 제조방법 | |
JP4441032B2 (ja) | 二官能性有機リン化合物、重合体、及び用途 | |
SU804656A1 (ru) | Полифенэтилсилсесквиоксаны-плен-КООбРАзующиЕ C пОВышЕННОйэлАТичНОСТью и СпОСОб иХ пОлучЕНи | |
MALAKPOUR et al. | Thionyl chloride/pyridine system as a condensing agent for the polyesterification reaction of N, N′-(4, 4′-oxydiphthaloyl)-bis-l-leucine and aromatic diols | |
JPH11255845A (ja) | グリコシルエチルメタクリレートをグラフト化してなるポリウレタン、製造方法および用途 | |
Dendele et al. | SYNTHESIS AND SURFACE MODIFICATION OF POLYETHERIMIDES BY REDUCTION, FOR TAILORED COMPOSITE MATERIALS PREPARATION | |
KR20160115259A (ko) | Peg 및 이온성 액체를 포함하는 폴리이미드, 이를 이용하여 제조한 고분자 막 및 그 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005502733 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004712183 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2006041160 Country of ref document: US Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10518462 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2004712183 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 10518462 Country of ref document: US |